{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:46:23Z","timestamp":1778841983363,"version":"3.51.4"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Adult cancer patients are at higher risk of morbidity and mortality following COVID-19 infection. Being on the front lines, it is crucial for emergency physicians to identify those who are at higher risk of mortality. The aim of our study was to determine the predictors of in-hospital mortality in COVID-19 positive cancer patients who present to the emergency department.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>This is a retrospective cohort study conducted on adult cancer patients who presented to the ED of the American university of Beirut medical center from February 21, 2020, till February 21, 2021, and were found to have COVID-19 infection. Relevant data was extracted and analyzed. The association between different variables and in-hospital mortality was tested using Student\u2019s <jats:italic>t<\/jats:italic> test and Fisher\u2019s exact test or Pearson\u2019s Chi-square where appropriate. Logistic regression was applied to factors with p &lt;0.2 in the univariate models.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The study included 89 distinct patients with an average age of 66 years (\u00b1 13.6). More than half of them were smokers (52.8%) and had received chemotherapy within 1 month of presentation (52.8%). About one third of the patients died (n = 31, 34.8%). Mortality was significantly higher in patients who had recently received chemotherapy (67.7% vs 44.8%, p = .039), a history of congestive heart failure (CHF)(p = .04), higher levels of CRP (p = 0.048) and\/or PCT(p&lt;0.04) or were tachypneic in the ED (P = 0.016).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Adult cancer patients with COVID-19 infection are at higher risks of mortality if they presented with tachypnea, had a recent chemotherapy, history of CHF, high CRP, and high procalcitonin levels at presentation.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0278898","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T18:33:29Z","timestamp":1674758009000},"page":"e0278898","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["\u201cPredictors of in-hospital mortality in adult cancer patients with COVID-19 infection presenting to the emergency department: A retrospective study\u201d"],"prefix":"10.1371","volume":"18","author":[{"given":"Imad","family":"El Majzoub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nour","family":"Kalot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malak","family":"Khalifeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Estelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1182-2435","authenticated-orcid":true,"given":"Tharwat","family":"El Zahran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,1,26]]},"reference":[{"key":"pone.0278898.ref001","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","author":"N Zhu","year":"2020","journal-title":"New England journal of medicine"},{"key":"pone.0278898.ref002","volume-title":"JAMA Health Forum","author":"D Cutler","year":"2020"},{"issue":"9","key":"pone.0278898.ref003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-021-01553-3","article-title":"Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?","volume":"38","author":"S Sinha","year":"2021","journal-title":"Medical Oncology"},{"key":"pone.0278898.ref004","doi-asserted-by":"crossref","first-page":"100285","DOI":"10.1016\/j.ctarc.2020.100285","article-title":"Cancer patients and COVID-19: Mortality, serious complications, biomarkers, and ways forward.","volume":"26","author":"K Gupta","year":"2021","journal-title":"Cancer Treatment and Research Communications"},{"issue":"7","key":"pone.0278898.ref005","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1158\/2159-8290.CD-20-0516","article-title":"Case fatality rate of cancer patients with COVID-19 in a New York hospital system","volume":"10","author":"V Mehta","year":"2020","journal-title":"Cancer discovery"},{"issue":"3","key":"pone.0278898.ref006","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"W Liang","year":"2020","journal-title":"The lancet oncology"},{"issue":"2","key":"pone.0278898.ref007","doi-asserted-by":"crossref","first-page":"pkaa102","DOI":"10.1093\/jncics\/pkaa102","article-title":"A systematic review and meta-analysis of cancer patients affected by a novel coronavirus","volume":"5","author":"BP Venkatesulu","year":"2021","journal-title":"JNCI Cancer Spectrum"},{"issue":"10241","key":"pone.0278898.ref008","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study","volume":"395","author":"NM Kuderer","year":"2020","journal-title":"The Lancet"},{"issue":"1","key":"pone.0278898.ref009","first-page":"1","article-title":"Reorganising the emergency department to manage the COVID-19 outbreak","volume":"13","author":"LJJ Quah","year":"2020","journal-title":"International journal of emergency medicine"},{"issue":"2","key":"pone.0278898.ref010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/emp2.12034","article-title":"Novel coronavirus 2019 (COVID\u201019): Emergence and implications for emergency care","volume":"1","author":"J Yee","year":"2020","journal-title":"Journal of the American College of Emergency Physicians Open"},{"issue":"7","key":"pone.0278898.ref011","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/anae.15072","article-title":"Hospital surge capacity in a tertiary emergency referral centre during the COVID\u201019 outbreak in Italy.","volume":"75","author":"L Carenzo","year":"2020","journal-title":"Anaesthesia"},{"issue":"16","key":"pone.0278898.ref012","doi-asserted-by":"crossref","first-page":"9122","DOI":"10.1073\/pnas.2004064117","article-title":"Projecting hospital utilization during the COVID-19 outbreaks in the United States","volume":"117","author":"SM Moghadas","year":"2020","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"13","key":"pone.0278898.ref013","doi-asserted-by":"crossref","first-page":"2000323","DOI":"10.2807\/1560-7917.ES.2020.25.13.2000323","article-title":"Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020.","volume":"25","author":"F Verelst","year":"2020","journal-title":"Eurosurveillance"},{"key":"pone.0278898.ref014","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejca.2020.05.028","article-title":"High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR","volume":"135","author":"S Assaad","year":"2020","journal-title":"European Journal of Cancer"},{"key":"pone.0278898.ref015","article-title":"ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan, China","author":"J Lu","year":"2020"},{"issue":"6","key":"pone.0278898.ref016","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/cid\/ciaa414","article-title":"Prediction for progression risk in patients with COVID-19 pneumonia: the CALL score","volume":"71","author":"D Ji","year":"2020","journal-title":"Clinical Infectious Diseases"},{"issue":"7","key":"pone.0278898.ref017","doi-asserted-by":"crossref","first-page":"e0236618","DOI":"10.1371\/journal.pone.0236618","article-title":"Prediction model and risk scores of ICU admission and mortality in COVID-19.","volume":"15","author":"Z Zhao","year":"2020","journal-title":"PloS one"},{"issue":"6","key":"pone.0278898.ref018","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/ejhf.1871","article-title":"COVID\u201019 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease.","volume":"22","author":"D Tomasoni","year":"2020","journal-title":"European journal of heart failure"},{"issue":"1","key":"pone.0278898.ref019","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ihj.2020.12.002","article-title":"Impact of congestive heart failure and role of cardiac biomarkers in COVID-19 patients: A systematic review and meta-analysis","volume":"73","author":"T Dalia","year":"2021","journal-title":"Indian heart journal."},{"issue":"30","key":"pone.0278898.ref020","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1200\/JCO.20.01307","article-title":"Chemotherapy and COVID-19 outcomes in patients with cancer","volume":"38","author":"J Jee","year":"2020","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"pone.0278898.ref021","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jnci\/djaa168","article-title":"Clinical characteristics and outcomes of COVID-19\u2013infected cancer patients: a systematic review and meta-analysis.","volume":"113","author":"H Zhang","year":"2021","journal-title":"JNCI: Journal of the National Cancer Institute"},{"issue":"3","key":"pone.0278898.ref022","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/cam4.3692","article-title":"The effect of anticancer treatment on cancer patients with COVID\u201019: A systematic review and meta\u2010analysis","volume":"10","author":"H Liu","year":"2021","journal-title":"Cancer medicine"},{"issue":"7","key":"pone.0278898.ref023","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S1470-2045(20)30310-7","article-title":"Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study","volume":"21","author":"K Yang","year":"2020","journal-title":"The Lancet Oncology"},{"issue":"6","key":"pone.0278898.ref024","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.annonc.2021.02.024","article-title":"Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.","volume":"32","author":"P Grivas","year":"2021","journal-title":"Annals of oncology"},{"key":"pone.0278898.ref025","author":"N Sharafeldin","year":"2021"},{"issue":"4","key":"pone.0278898.ref026","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.annemergmed.2020.07.022","article-title":"Development and validation of the quick COVID-19 severity index: a prognostic tool for early clinical decompensation","volume":"76","author":"AD Haimovich","year":"2020","journal-title":"Annals of emergency medicine"},{"key":"pone.0278898.ref027","article-title":"Admission respiratory status predicts mortality in COVID\u201019.","author":"NA Chatterjee","year":"2021","journal-title":"Influenza and Other Respiratory Viruses"},{"issue":"11","key":"pone.0278898.ref028","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1164\/rccm.202003-0736LE","article-title":"Clinical course and outcomes of 344 intensive care patients with COVID-19","volume":"201","author":"Y Wang","year":"2020","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"5","key":"pone.0278898.ref029","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"W Lim","year":"2003","journal-title":"Thorax"},{"issue":"4","key":"pone.0278898.ref030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"MJ Fine","year":"1997","journal-title":"New England journal of medicine"},{"issue":"29\u201330","key":"pone.0278898.ref031","first-page":"503","article-title":"The prognostic significance of respiratory rate in patients with pneumonia.","volume":"111","author":"R Straub","year":"2014","journal-title":"Dtsch Arztebl Int"},{"issue":"7","key":"pone.0278898.ref032","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/jmv.25871","article-title":"C\u2010reactive protein correlates with computed tomographic findings and predicts severe COVID\u201019 early","volume":"92","author":"C Tan","year":"2020","journal-title":"Journal of medical virology"},{"key":"pone.0278898.ref033","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/B978-0-12-416687-5.00007-5","article-title":"Clinical Enzymology and Biomarkers of Tissue Injury","author":"NV Bhagavan","year":"2015","journal-title":"Essentials of Medical Biochemistry"},{"issue":"4","key":"pone.0278898.ref034","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/07853890009011772","article-title":"Function of C-reactive protein","volume":"32","author":"TW Du Clos","year":"2009","journal-title":"Annals of Medicine"},{"issue":"1","key":"pone.0278898.ref035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1586\/eri.10.154","article-title":"Biomarkers for pediatric sepsis and septic shock","volume":"9","author":"SW Standage","year":"2011","journal-title":"Expert review of anti-infective therapy"},{"issue":"1","key":"pone.0278898.ref036","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41392-021-00679-0","article-title":"The signal pathways and treatment of cytokine storm in COVID-19","volume":"6","author":"L Yang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"pone.0278898.ref037","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3390\/v12040372","article-title":"Virology, epidemiology, pathogenesis, and control of COVID-19","volume":"12","author":"Y Jin","year":"2020","journal-title":"Viruses"},{"key":"pone.0278898.ref038","doi-asserted-by":"crossref","first-page":"108427","DOI":"10.1016\/j.clim.2020.108427","article-title":"COVID-19 pathophysiology: A review.","volume":"215","author":"K Yuki","year":"2020","journal-title":"Clinical immunology"},{"issue":"3","key":"pone.0278898.ref039","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1097\/MJT.0000000000000210","article-title":"Procalcitonin as biomarker of infection: implications for evaluation and treatment.","volume":"24","author":"PF Gon\u00e7alves","year":"2017","journal-title":"American journal of therapeutics"},{"issue":"1","key":"pone.0278898.ref040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40560-017-0246-8","article-title":"Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy","volume":"5","author":"AL Vijayan","year":"2017","journal-title":"Journal of intensive care"},{"issue":"3","key":"pone.0278898.ref041","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/cid\/ciz545","article-title":"Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis","volume":"70","author":"IS Kamat","year":"2020","journal-title":"Clinical Infectious Diseases"},{"key":"pone.0278898.ref042","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cca.2020.03.004","article-title":"Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis.","volume":"505","author":"G Lippi","year":"2020","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"key":"pone.0278898.ref043","doi-asserted-by":"crossref","first-page":"1753466620937175","DOI":"10.1177\/1753466620937175","article-title":"C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis","volume":"14","author":"I Huang","year":"2020","journal-title":"Therapeutic advances in respiratory disease"},{"issue":"1","key":"pone.0278898.ref044","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.cllc.2020.08.002","article-title":"Tocilizumab for COVID-19 Pneumonia in a Patient With Non\u2013Small-cell Lung Cancer Treated With Chemoimmunotherapy.","volume":"22","author":"M Bonomi","year":"2021","journal-title":"Clinical Lung Cancer"},{"issue":"7","key":"pone.0278898.ref045","doi-asserted-by":"crossref","first-page":"102568","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy.","volume":"19","author":"P Toniati","year":"2020","journal-title":"Autoimmunity reviews"},{"issue":"1","key":"pone.0278898.ref046","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pulmoe.2020.07.003","article-title":"Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review.","volume":"27","author":"A Cortegiani","year":"2021","journal-title":"Pulmonology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0278898","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T18:34:06Z","timestamp":1674758046000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0278898"}},"subtitle":[],"editor":[{"given":"Ogochukwu Chinedum","family":"Okoye","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0278898","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,26]]}}}